Insulin-like-growth-factor

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

IGF; IGF1; IGF-1; IGF-I; IGF-II; Insulin-like growth factor; Insulin-like-growth-factor-I; Insulin-like-growth-factor-II; SM-A; Somatomedin A; Somatomedin C

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Polypeptides with high sequence homology to insulin. Their synthesis takes place primarily in the liver. The "insulin-like-growth-factors" are part of a complex system of growth factors (GH = growth factor), which body cells use to communicate with their environment. This system consists of two membrane receptors (IGF1R and IGF2R), two ligands, a group of six IGF binding proteins (IGFBP 1-6), and some IGFBP-associated proteases.

General informationThis section has been translated automatically.

  • IGF-1: Growth factor structurally very similar to insulin. Like IGF-2, it is mainly secreted by the liver after stimulation. An influence of IGF-1 on the regulation of physiological as well as pathological states (here especially in tumor development) has been demonstrated. Meals with a high glycaemic load lead to an induction of insulin and IGF-1, and influences on cell proliferation and inhibition of apoptosis have been described. IgF-1 shows the highest physiological serum concentrations in adolescence between 15 and 20 years of age. IGF-1 seems to play a role in the pathogenesis of acne vulgaris. An IGF-1 gene polymorphism associated with acne has been identified (Tasli L et al. 2013). IGE-1 induces proliferation in keratinocytes. Furthermore, it inhibits the transcription factor FoxO1 in sebocytes (Mirdamadi Y et al. 2015). FoxO1 is a suppressor of important transcription factors in lipid synthesis. As a consequence, IGF-1 induces sebocyte lipogenesis and acts costimulatively with androgens in sebocytes with respect to proliferation and lipogenesis. The facial sebum concentration correlates with the IGF-1 serum concentration in male acne patients.
  • IGF-2: Plays an important role in early cell development, e.g. in the development of infant hemangiomas (here an upregulation of IgF-2 could be shown), while IGF-1 is rather responsible for growth acceleration at a later stage.

LiteratureThis section has been translated automatically.

  1. Mirdamadi Y et al (2015) Insulin and insulin-like-growth-factor-1 can modulate thephosphoinositide-3-kinase/Akt/FoxO1
    pathway in SZ95 sebocytes in vitro.
    Mol cell endocrinol 415:32-44.
  2. Plewig G (2010) How does acne vulgaris develop? dermatologist 61: 99-106
  3. Tasli L et al (2013) Insulin-like growth factor-I gene polymorphism in acne vulgaris. J Eur Acad Dermatol Venereol 27: 254-257.

Authors

Last updated on: 29.10.2020